Exciting Pharma success with interesting Capital Structure.
Focused upon Schizophrenia..
Should be enetering 2 Phase 3 for Schizophrenia soon.
have not done the due dilligence necessary to give finality to data sets..
on quick first glance..I am not a researcher..so take everything with GRAIN OF SALT!!
i think this is being managed for purchase..my first gut feel..
will update as I learn more.
at $70,000,000 market cap ..i think its undervalued..
target for sale is $1 billion or around $50..per share..
has Warrants..rvphw..CAVEAT EMPTOR..
i THINK the rvphw could be interesting play..if buyout..
do your own due dilligence..